Efficacy and safety of ustekinumab and vedolizumab in very early‐onset inflammatory bowel disease: A multicenter study from the pediatric inflammatory bowel disease Porto Group of ESPGHAN
Luca Scarallo,
Paolo Lionetti,
Jaroslaw Kierkus,
Lauren Collen,
Victoria Riedl,
Christian Jakobsen,
Gemma Pujol‐Muncunill,
Kaija‐Leena Kolho,
Marta Velasco Rodriguez‐Belvis,
Katarina Mitrova,
Darja Urlep,
Benedicte Pigneur,
Seamus Hussey,
Firas Rinawi,
Jan De Laffolie,
Karl Mårild,
Anat Yerushalmy‐Feler,
Raffi Lev Tzion,
Maya Granot,
Marina Aloi,
Elisabeth De Greef,
Christos Tzvinikos,
Christoph Norden,
Caterina Strisciuglio,
Kwang Yang Lee,
Rémi Duclaux‐Loras,
Saverio Journal of Pediatric Gastroenterology and Nutrition
· Wiley
· 2026-11-06
· DOI: 10.1002/jpn3.70645
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Luca Scarallo, Paolo Lionetti, Jaroslaw Kierkus, Lauren Collen, Victoria Riedl, Christian Jakobsen et al. Efficacy and safety of ustekinumab and vedolizumab in very early‐onset inflammatory bowel disease: A multicenter study from the pediatric inflammatory bowel disease Porto Group of ESPGHAN. // Journal of Pediatric Gastroenterology and Nutrition. – 2026. – DOI: 10.1002/jpn3.70645. – URL: https://onlinelibrary.wiley.com/doi/10.1002/jpn3.70645?af=R
Luca Scarallo, Paolo Lionetti, Jaroslaw Kierkus, Lauren Collen, Victoria Riedl, Christian Jakobsen, Gemma Pujol‐Muncunill, Kaija‐Leena Kolho, Marta Velasco Rodriguez‐Belvis, Katarina Mitrova, Darja Urlep, Benedicte Pigneur, Seamus Hussey, Firas Rinawi, Jan De Laffolie, Karl Mårild, Anat Yerushalmy‐Feler, Raffi Lev Tzion, Maya Granot, Marina Aloi, Elisabeth De Greef, Christos Tzvinikos, Christoph Norden, Caterina Strisciuglio, Kwang Yang Lee, Rémi Duclaux‐Loras, & Saverio (2026). Efficacy and safety of ustekinumab and vedolizumab in very early‐onset inflammatory bowel disease: A multicenter study from the pediatric inflammatory bowel disease Porto Group of ESPGHAN. Journal of Pediatric Gastroenterology and Nutrition. https://doi.org/10.1002/jpn3.70645
Luca Scarallo, et al. “Efficacy and safety of ustekinumab and vedolizumab in very early‐onset inflammatory bowel disease: A multicenter study from the pediatric inflammatory bowel disease Porto Group of ESPGHAN.” Journal of Pediatric Gastroenterology and Nutrition, 2026. doi:10.1002/jpn3.70645.
@article{Scarallo2026,
title = {Efficacy and safety of ustekinumab and vedolizumab in very early‐onset inflammatory bowel disease: A multicenter study from the pediatric inflammatory bowel disease Porto Group of ESPGHAN},
author = {Scarallo, Luca and Lionetti, Paolo and Kierkus, Jaroslaw and Collen, Lauren and Riedl, Victoria and Jakobsen, Christian and Pujol‐Muncunill, Gemma and Kolho, Kaija‐Leena and Rodriguez‐Belvis, Marta Velasco and Mitrova, Katarina and Urlep, Darja and Pigneur, Benedicte and Hussey, Seamus and Rinawi, Firas and Laffolie, Jan De and Mårild, Karl and Yerushalmy‐Feler, Anat and Tzion, Raffi Lev and Granot, Maya and Aloi, Marina and Greef, Elisabeth De and Tzvinikos, Christos and Norden, Christoph and Strisciuglio, Caterina and Lee, Kwang Yang and Duclaux‐Loras, Rémi and Saverio},
journal = {Journal of Pediatric Gastroenterology and Nutrition},
year = {2026},
doi = {10.1002/jpn3.70645},
url = {https://onlinelibrary.wiley.com/doi/10.1002/jpn3.70645?af=R}
}
ABSTRACT Aim To investigate the longitudinal association between early‐life movement behaviour patterns and later clinically diagnosed obesity. Method In the population‐based All Babies in Southeast Sweden (ABIS) cohort, 16 415 children...